Package 0006-0005-13

{"route": ["ORAL"], "spl_id": "21306af5-e07a-4f8e-8f59-3e0aacc53102", "openfda": {"nui": ["N0000191000", "N0000190998", "N0000185503", "N0000190114"], "unii": ["081L192FO9"], "rxcui": ["1547104", "1547110", "1547112", "1547114", "1547116", "1547118", "1547573", "1547575"], "spl_set_id": ["e5b72731-1acb-45b7-9c13-290ad12d3951"], "pharm_class_epc": ["Orexin Receptor Antagonist [EPC]"], "pharm_class_moa": ["Orexin Receptor Antagonists [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]"], "manufacturer_name": ["Merck Sharp & Dohme LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CASE (0006-0005-13)  / 3 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0006-0005-13", "marketing_start_date": "20140829"}, {"sample": false, "description": "3 CASE in 1 CARTON (0006-0005-30)  / 1 BLISTER PACK in 1 CASE (0006-0005-10)  / 10 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0006-0005-30", "marketing_start_date": "20140829"}], "brand_name": "BELSOMRA", "product_id": "0006-0005_21306af5-e07a-4f8e-8f59-3e0aacc53102", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 3A Inhibitors [MoA]", "Orexin Receptor Antagonist [EPC]", "Orexin Receptor Antagonists [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "0006-0005", "dea_schedule": "CIV", "generic_name": "suvorexant", "labeler_name": "Merck Sharp & Dohme LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BELSOMRA", "active_ingredients": [{"name": "SUVOREXANT", "strength": "5 mg/1"}], "application_number": "NDA204569", "marketing_category": "NDA", "marketing_start_date": "20140829", "listing_expiration_date": "20261231"}